Back
TRACKER - Insider TradesOfficial account @insider-trades
KOD long @ 27.95

Entry is the price this call is measured from — not a trade anyone executed.

3.50 30.48 57.47 84.46 111.44 Oct 17 Jan 23 May 1 Aug 7 Oct 29 apesalpha.com TRADED Dec 18 ENTRY 27.95
Entry 27.95 At close 100.40 +259.2% vs entry 216 sessions since the post 2025-10-17 → 2026-10-29 weekly bars traded Dec 18, filed later

Baker Brothers Life Sciences LP has been buying KOD.

  1. The buy: Baker Brothers Life Sciences LP, a Director, bought 2,608,696 shares of KOD on 18 December 2025 — $60,000,008 at $23.00 a share.
  2. The entry above is not that price. A Form 4 discloses what they paid on their own trade date, which was before anyone else could see it. Ours is the opening price on the first session after this became public.
  3. Filed: 19 December 2025.

Risk: this is an INSTITUTION, not an executive. A fund or trust with a board seat or a 10% stake is building a position, and it may be averaging in, hedged elsewhere, or acting on a mandate that has nothing to do with a view on the next quarter. That is a different signal from a chief executive buying their own stock, which is why it posts here rather than under Big Insider Buys. An automated tracker of public SEC filings, not a recommendation.

· Fri, 19 Dec 2025 · · 8 views 8 clicks

0 comments

No comments yet.

You’re posting as a guest. Sign in to post under your own name.